Australasian Resuscitation In Sepsis Evaluation trial statistical analysis plan

Research output: Contribution to journalArticleOther

4 Citations (Scopus)

Abstract

The Australasian Resuscitation In Sepsis Evaluation (ARISE) study is an international, multicentre, randomised, controlled trial designed to evaluate the effectiveness of early goal-directed therapy compared with standard care for patients presenting to the ED with severe sepsis. Objective: In keeping with current practice, and taking into considerations aspects of trial design and reporting speci?c to non-pharmacologic interventions, this document outlines the principles and methods for analysing and reporting the trial results. The document is prepared prior to completion of recruitment into the ARISE study, without knowledge of the results of the interim analysis conducted by the data safety and monitoring committee and prior to completion of the two related international studies. Methods: The statistical analysis plan was designed by the ARISE chief investigators, and reviewed and approved by the ARISE steering committee. The data collected by the research team as speci?ed in the study protocol, and detailed in the study case report form were reviewed. Information related to baseline characteristics, characteristics of delivery of the trial interventions, details of resuscitation and other related therapies, and other relevant data are described with appropriate comparisons between groups. The primary, secondary and tertiary outcomes for the study are de?ned, with description of the planned statistical analyses. Results: A statistical analysis plan was developed, along with a trial pro?le, mock-up tables and ?gures. A plan for presenting baseline characteristics, microbiological and antibiotic therapy, details of the interventions, processes of care and concomitant therapies, along with adverse events are described. The primary, secondary and tertiary outcomes are described along with identi?cation of subgroups to be analysed. Conclusion: A statistical analysis plan for the ARISE study has been developed, and is available in th
Original languageEnglish
Pages (from-to)406 - 415
Number of pages10
JournalEMA - Emergency Medicine Australasia
Volume25
Issue number5
DOIs
Publication statusPublished - 2013

Cite this

@article{8113e193082447328af63c128ea37eb0,
title = "Australasian Resuscitation In Sepsis Evaluation trial statistical analysis plan",
abstract = "The Australasian Resuscitation In Sepsis Evaluation (ARISE) study is an international, multicentre, randomised, controlled trial designed to evaluate the effectiveness of early goal-directed therapy compared with standard care for patients presenting to the ED with severe sepsis. Objective: In keeping with current practice, and taking into considerations aspects of trial design and reporting speci?c to non-pharmacologic interventions, this document outlines the principles and methods for analysing and reporting the trial results. The document is prepared prior to completion of recruitment into the ARISE study, without knowledge of the results of the interim analysis conducted by the data safety and monitoring committee and prior to completion of the two related international studies. Methods: The statistical analysis plan was designed by the ARISE chief investigators, and reviewed and approved by the ARISE steering committee. The data collected by the research team as speci?ed in the study protocol, and detailed in the study case report form were reviewed. Information related to baseline characteristics, characteristics of delivery of the trial interventions, details of resuscitation and other related therapies, and other relevant data are described with appropriate comparisons between groups. The primary, secondary and tertiary outcomes for the study are de?ned, with description of the planned statistical analyses. Results: A statistical analysis plan was developed, along with a trial pro?le, mock-up tables and ?gures. A plan for presenting baseline characteristics, microbiological and antibiotic therapy, details of the interventions, processes of care and concomitant therapies, along with adverse events are described. The primary, secondary and tertiary outcomes are described along with identi?cation of subgroups to be analysed. Conclusion: A statistical analysis plan for the ARISE study has been developed, and is available in th",
author = "Anthony Delaney and Peake, {Sandra Lois} and Rinaldo Bellomo and Peter Cameron and Anna Holdgate and Howe, {Belinda Duval} and Alisa Higgins and Presneill, {Jeffrey J} and Steven Webb",
year = "2013",
doi = "10.1111/1742-6723.12116",
language = "English",
volume = "25",
pages = "406 -- 415",
journal = "EMA - Emergency Medicine Australasia",
issn = "1742-6731",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Australasian Resuscitation In Sepsis Evaluation trial statistical analysis plan

AU - Delaney, Anthony

AU - Peake, Sandra Lois

AU - Bellomo, Rinaldo

AU - Cameron, Peter

AU - Holdgate, Anna

AU - Howe, Belinda Duval

AU - Higgins, Alisa

AU - Presneill, Jeffrey J

AU - Webb, Steven

PY - 2013

Y1 - 2013

N2 - The Australasian Resuscitation In Sepsis Evaluation (ARISE) study is an international, multicentre, randomised, controlled trial designed to evaluate the effectiveness of early goal-directed therapy compared with standard care for patients presenting to the ED with severe sepsis. Objective: In keeping with current practice, and taking into considerations aspects of trial design and reporting speci?c to non-pharmacologic interventions, this document outlines the principles and methods for analysing and reporting the trial results. The document is prepared prior to completion of recruitment into the ARISE study, without knowledge of the results of the interim analysis conducted by the data safety and monitoring committee and prior to completion of the two related international studies. Methods: The statistical analysis plan was designed by the ARISE chief investigators, and reviewed and approved by the ARISE steering committee. The data collected by the research team as speci?ed in the study protocol, and detailed in the study case report form were reviewed. Information related to baseline characteristics, characteristics of delivery of the trial interventions, details of resuscitation and other related therapies, and other relevant data are described with appropriate comparisons between groups. The primary, secondary and tertiary outcomes for the study are de?ned, with description of the planned statistical analyses. Results: A statistical analysis plan was developed, along with a trial pro?le, mock-up tables and ?gures. A plan for presenting baseline characteristics, microbiological and antibiotic therapy, details of the interventions, processes of care and concomitant therapies, along with adverse events are described. The primary, secondary and tertiary outcomes are described along with identi?cation of subgroups to be analysed. Conclusion: A statistical analysis plan for the ARISE study has been developed, and is available in th

AB - The Australasian Resuscitation In Sepsis Evaluation (ARISE) study is an international, multicentre, randomised, controlled trial designed to evaluate the effectiveness of early goal-directed therapy compared with standard care for patients presenting to the ED with severe sepsis. Objective: In keeping with current practice, and taking into considerations aspects of trial design and reporting speci?c to non-pharmacologic interventions, this document outlines the principles and methods for analysing and reporting the trial results. The document is prepared prior to completion of recruitment into the ARISE study, without knowledge of the results of the interim analysis conducted by the data safety and monitoring committee and prior to completion of the two related international studies. Methods: The statistical analysis plan was designed by the ARISE chief investigators, and reviewed and approved by the ARISE steering committee. The data collected by the research team as speci?ed in the study protocol, and detailed in the study case report form were reviewed. Information related to baseline characteristics, characteristics of delivery of the trial interventions, details of resuscitation and other related therapies, and other relevant data are described with appropriate comparisons between groups. The primary, secondary and tertiary outcomes for the study are de?ned, with description of the planned statistical analyses. Results: A statistical analysis plan was developed, along with a trial pro?le, mock-up tables and ?gures. A plan for presenting baseline characteristics, microbiological and antibiotic therapy, details of the interventions, processes of care and concomitant therapies, along with adverse events are described. The primary, secondary and tertiary outcomes are described along with identi?cation of subgroups to be analysed. Conclusion: A statistical analysis plan for the ARISE study has been developed, and is available in th

U2 - 10.1111/1742-6723.12116

DO - 10.1111/1742-6723.12116

M3 - Article

VL - 25

SP - 406

EP - 415

JO - EMA - Emergency Medicine Australasia

JF - EMA - Emergency Medicine Australasia

SN - 1742-6731

IS - 5

ER -